|
|
|
MIRA INFORM REPORT
|
Report No. : |
486069 |
|
Report Date : |
12.01.2018 |
IDENTIFICATION DETAILS
|
Name : |
BIOFAC JAPAN LTD |
|
|
|
|
Registered Office : |
Sanei Fushimi Bldg 3F, 2-15-20 Nishiki Nakaku Nagoya 460-0003 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
30.06.2017 |
|
|
|
|
Date of Incorporation : |
May 2015 |
|
|
|
|
Com. Reg. No.: |
1800-01-118791 |
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
Line of Business : |
A trading for import, export & wholesale of food additives,
beverages, pharmaceuticals, other |
|
|
|
|
No. of Employees : |
4 |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
B |
|
Credit Rating |
Explanation |
Rating Comments |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
Maximum Credit Limit : |
Yen 9.0 Million |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but Correct |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.06.2017) |
Current Rating (30.09.2017) |
|
Japan |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
JAPAN - ECONOMIC OVERVIEW
Over the past 70 years, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (slightly less than 1% of GDP) have helped Japan develop an advanced economy. Two notable characteristics of the post-World War II economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features have significantly eroded under the dual pressures of global competition and domestic demographic change.
Measured on a purchasing power parity basis that adjusts for price differences, Japan in 2016 stood as the fourth-largest economy in the world after first-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2012. For three postwar decades, overall real economic growth was impressive - a 10% average in the 1960s, 5% in the 1970s, and 4% in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the aftereffects of inefficient investment and the collapse of an asset price bubble in the late 1980s, which entailed considerable time for firms to reduce excess debt, capital, and labor. Modest economic growth continued after 2000, but the economy has fallen into recession four times since 2008.
Japan enjoyed an uptick in growth in 2013 on the basis of Prime Minister Shinzo ABE’s “Three Arrows” economic revitalization agenda - dubbed “Abenomics” - of monetary easing, “flexible” fiscal policy, and structural reform. Led by the Bank of Japan’s aggressive monetary easing, Japan is making modest progress in ending deflation, but demographic decline – a low birthrate and an aging, shrinking population – poses a major long-term challenge for the economy. The government currently faces the quandary of balancing its efforts to stimulate growth and institute economic reforms with the necessity of addressing its sizable public debt, which stands at 235% of GDP. To help raise government revenue, Japan adopted legislation in 2012 to gradually raise the consumption tax rate. However, the first such increase, in April 2014, led to another recession, so Prime Minister ABE has twice postponed the next increase, now scheduled for October 2019. Structural reforms to unlock productivity are seen as central to strengthening the economy in the long-run.
Scarce in critical natural resources, Japan has long been dependent on imported energy and raw materials. After the complete shutdown of Japan’s nuclear reactors following the earthquake and tsunami disaster in 2011, Japan's industrial sector has become even more dependent than before on imported fossil fuels. However, ABE’s government is seeking to restart nuclear power plants that meet strict new safety standards and is emphasizing nuclear energy’s importance as a base-load electricity source. In August 2015, Japan successfully restarted one nuclear reactor at the Sendai Nuclear Power Plant in Kagoshima prefecture, and several other reactors around the country have since resumed operations; however, opposition from local governments has delayed several more restarts that remain pending. Reforms of the electricity and gas sectors, including full liberalization of Japan’s energy market in April 2016 and gas market in April 2017, constitute an important part of Prime Minister Abe’s economic program.
In October 2015, Japan and 11 trading partners reached
agreement on the Trans-Pacific Partnership (TPP), a pact that had promised to
open Japan's economy to increased foreign competition and create new export
opportunities for Japanese businesses. Japan was the second country to ratify
the TPP in December 2016; the United States signaled its withdrawal from the
TPP on January 23, 2017, and as of April 2017 the agreement has not gone into
effect.
|
Source
: CIA |
COMPANY
NAME AND SUMMARY
BIOFAC
JAPAN LTD
REGD
NAME: Nippon Biofac KK
MAIN
OFFICE: Sanei Fushimi Bldg 3F, 2-15-20 Nishiki
Nakaku Nagoya 460-0003 JAPAN
Tel:
052-228-0610 Fax: 052-228-0620
E-Mail address: (Thru the URL)
ACTIVITIES: Import, export, wholesale of food
additives, other
BRANCHES: Nil
OVERSEAS: Denmark (the parent)
OFFICERS: HISANOBU
SHIMIZU, PRES
Yen Amount: In
million Yen, unless otherwise stated
SUMMARY: FINANCES R/WEAK A/SALES Yen 500 M
PAYMENTS SLOW BUT CORRECT CAPITAL Yen 15 M
TREND SLOW WORTH Yen 74 M
STARTED 2015 EMPLOYES 4
COMMENT
TRADING FIRM SPECIALIZING IN FOOD ADDITIVES, OTHER.
FINANCIAL SITUATION CONSIDERED R/WEAK BUT SHOULD BE GOOD FOR MODERATE
BUSINESS ENGAGEMENTS.
MAX CREDIT LIMIT: ESTIMATED AT YEN 9.0
MILLION, ON 30 DAYS NORMAL TERMS.
HIGHLIGHTS
The subject
company is a trading firm for import, export & wholesale of food additives,
beverages, pharmaceuticals, other, owned by Biofac Group in Denmark. Clients include pharma makers, wholesalers,
other
FINANCIAL
INFORMATION
Financials are disclosed
only partially.
The sales volume
for Jun/2017 fiscal term amounted to Yen 500 million, a similar amount in the
previous term. The net profit was posted
at Yen 30 million, similarly a year ago, respectively, a year ago.
For the current
term ending Jun 2018 the net profit is projected at Yen 32 million, on a 4%
rise in turnover, to Yen 520 million.
The financial
situation is considered R/WEAK but should be good for MODERATE business
engagements. Max credit limit is
estimated at Yen 9.0 million, on 30 days normal terms.
REGISTRATION
Date Registered: May 2015
Regd No.: 1800-01-118791 (Nagoya-Nakaku)
Legal Status: Limited Company
(Kabushiki Kaisha)
Authorized: 1,200 shares
Issued: 300 shares
Sum: Yen 15 million
Major
shareholders (%): Peter Lobic Holdings Co (Denmark) (100)
Nothing
detrimental is known as to the commercial morality of executives.
OPERATION
Activities: A trading for
import, export & wholesale of food additives, beverages, pharmaceuticals,
other (--100%)
Clients: [Mfrs,
wholesalers] Zeria Shin-Yaku Ind, Sogo Trading, Ask Pharmaceuticals, other
No. of accounts: 200
Domestic areas of activities: Nationwide
Suppliers: [Mfrs,
wholesalers] Biobac AS (100%)
Payment
record: Slow but correct
Location: Business area in Nagoya. Office premises at the caption address are
leased and maintained satisfactorily.
Bank
References:
Resona
Bank (Nagoya)
Relations:
Satisfactory
FINANCES
(In
Million Yen)
|
Terms Ending: |
|
30/06/2018 |
30/06/2017 |
30/06/2016 |
30/06/2015 |
|
Annual Sales |
|
520 |
500 |
500 |
0 |
|
Recur. Profit |
|
.. |
.. |
.. |
.. |
|
Net Profit |
|
32 |
30 |
30 |
-3 |
|
Total Assets |
|
|
N/A |
N/A |
N/A |
|
Net Worth |
|
|
74 |
44 |
14 |
|
Capital, Paid-Up |
|
|
15 |
15 |
15 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
|
(%) |
(%) |
(%) |
(%) |
|
S.Growth Rate |
|
4.00 |
0.00 |
- - - |
- - - |
|
Current Ratio |
|
|
.. |
.. |
.. |
|
N.Worth Ratio |
|
|
.. |
.. |
.. |
|
N.Profit/Sales |
|
6.15 |
6.00 |
6.00 |
- - - |
Notes: Financials are only partially
disclosed.
Forecast (or estimated) figures for the
30/06/2018 fiscal term.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
INR 63.74 |
|
|
1 |
INR 86.01 |
|
Euro |
1 |
INR 76.14 |
|
Yen |
1 |
INR 0.57 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
VIV |
|
|
|
|
Report Prepared
by : |
SYL |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low risk
of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably on
secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the business
is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.